Literature DB >> 32931267

Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling.

Lingfeng Chen1,2,3, Lulu Zheng4, Pengqin Chen1, Guang Liang1,3.   

Abstract

Myeloid differentiation primary response protein 88 (MyD88) is a ubiquitously expressed cytoplasmic adaptor protein that plays a central role in the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways. TLR/IL-1R pathways regulate the proliferation and differentiation of cells involved in the innate and adaptive immunity. Although the general TLR/IL-1R activation cascade is well understood, the molecular mechanisms involving MyD88 have only begun to surface in the past decade. In this review, we explore MyD88 structural biology, the role of posttranslational modifications (PTMs), and the recent developments in MyD88 inhibitor discovery and use. We also highlight the potential application of MyD88-targeted therapies in human diseases.

Entities:  

Year:  2020        PMID: 32931267     DOI: 10.1021/acs.jmedchem.0c00884

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  MyD88 Deficiency, but Not Gut Microbiota Depletion, Is Sufficient to Modulate the Blood-Brain Barrier Function in the Mediobasal Hypothalamus.

Authors:  Christina N Heiss; Ellinor Gravert; Matilda Hultén; Louise E Olofsson
Journal:  Mol Neurobiol       Date:  2022-04-06       Impact factor: 5.682

2.  MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas.

Authors:  Qinglong Guo; Xing Xiao; Jinsen Zhang
Journal:  Front Oncol       Date:  2021-04-07       Impact factor: 6.244

3.  Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients.

Authors:  Sergio Ramirez-Perez; Edith Oregon-Romero; Itzel Viridiana Reyes-Perez; Pallavi Bhattaram
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

4.  Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages.

Authors:  Young-Su Yi; Han Gyung Kim; Ji Hye Kim; Woo Seok Yang; Eunji Kim; Deok Jeong; Jae Gwang Park; Nur Aziz; Suk Kim; Narayanan Parameswaran; Jae Youl Cho
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

5.  Discovery of a Novel MyD88 Inhibitor M20 and Its Protection Against Sepsis-Mediated Acute Lung Injury.

Authors:  Jiali Song; Daoxing Chen; Yingqiao Pan; Xueqin Shi; Qian Liu; Xiaoyao Lu; Ximing Xu; Gaozhi Chen; Yuepiao Cai
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

Review 6.  The Emerging Roles of Pellino Family in Pattern Recognition Receptor Signaling.

Authors:  E Zhang; Xia Li
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

7.  Effects of adenovirus-mediated knockdown of IRAK4 on synovitis in the osteoarthritis rabbit model.

Authors:  Muzhe Li; Huiyun Li; Xun Ran; Han Yin; Xuling Luo; Zhiwei Chen
Journal:  Arthritis Res Ther       Date:  2021-12-04       Impact factor: 5.156

Review 8.  Role of HMGB1/TLR4 and IL-1β/IL-1R1 Signaling Pathways in Epilepsy.

Authors:  Shaohui Zhang; Feng Chen; Feng Zhai; Shuli Liang
Journal:  Front Neurol       Date:  2022-06-28       Impact factor: 4.086

Review 9.  Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.

Authors:  Jingyi Hu; Rong Zhang; Hailan Zou; Lingxiang Xie; Zhiguang Zhou; Yang Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-21       Impact factor: 6.055

Review 10.  The RING finger protein family in health and disease.

Authors:  Chunmei Cai; Yan-Dong Tang; Jingbo Zhai; Chunfu Zheng
Journal:  Signal Transduct Target Ther       Date:  2022-08-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.